Patent Assignment
Reel/Frame 036675/0407
Corrective Assignment to Correct the Receiving Party Data Previously Recorded at Reel: 036254 Frame: 0780. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2015-09-24
Pages: 8
Assignor
M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT
Executed: 2015-07-29
Assignee
VTVX HOLDINGS I LLC
4170 MENDENHALL OAKS PKWY, HIGH POINT, NORTH CAROLINA, 27265
Covered Properties
(53)
Methods to Identify Compounds That Modulate Rage
Patent:
6,908,741 →
Application:
09/799,152 →
Carboxamide Derivatives as Therapeutic Agents
Heteroaryl - Fused Nitrogen Heterocycles as Therapeutic Agents
Automated Systems for Weighing and/or Liquid Delivery
Patent:
6,898,549 →
Application:
10/332,114 →
Azole Derivatives and Fused Bicyclic Azole Derivatives as Therapeutic Agents
System and Method for Data Analysis, Manipulation, and Visualization
Aryl and Heteroaryl Compounds, Compositions, and Methods of Use
Aryl and Heteroaryl Compounds, Compositions, and Methods of Use
Aryl and Heteroaryl Compounds, Compositions and Methods of Use
Substituted Heteroaryl Derivatives, Compositions, and Methods of Use
Rage Fusion Proteins
Azole Derivatives and Fused Bicyclic Azole Derivatives as Therapeutic Agents
Rage Fusion Proteins
Substituted Imidazole Derivatives, Compositions, and Methods of Use as Ptpase Inhibitors
Benzazole Derivatives, Compositions, and Methods of Use as Aurora Kinase Inhibitors
Rage Fusion Proteins, Formulations, and Methods of Use Thereof
Heteroaromatic Glucokinase Activators
Azole Derivatives and Fused Bicyclic Azole Derivatives as Therapeutic Agents
Dicycloalkyl Urea Glucokinase Activators
Crystalline Forms of [3-(4- {2-Butyl- 1 -[4-(4-Chloro-Phenoxy)-Phenyl]-1H-Imidazol-4-Yl} -Phenoxy)-Propyl]-Diethyl-Amine
Benzamide Glucokinase Activators
Oxadiazoanthracene Compounds for the Treatment of Diabetes
Urea Glucokinase Activators
Substituted Aminothiazole Derivatives, Pharmaceutical Compositions, and Methods of Use
Substituted Imidazole Derivatives, Compositions, and Methods of Use as Ptpase Inhibitors
Benzazole Derivatives, Compositions, And Methods Of Use As Aurora Kinase Inhibitors
Oxadiazoanthracene Compounds for the Treatment of Diabetes
Substituted Azoanthracene Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof
Oxadiazoanthracene Compounds for the Treatment of Diabetes
Oxadiazoanthracene Compounds for the Treatment of Diabetes
Substituted Imidazole Derivatives And Methods Of Use Thereof
N-Heteroaryl Indole Carboxamides and Analogues Thereof, for Use as Glucokinase Activators in the Treatment of Diabetes
Probes, Systems, and Methods for Drug Discovery
Application:
12/901,133 →
Publication:
US 2011/0039714
Ligands For The GLP-1 Receptor And Methods For Discovery Thereof
Crystalline Forms of [3-(4- {2-Butyl- 1 -[4-(4-Chloro-Phenoxy)-Phenyl]-1H-Imidazol-4-Yl} -Phenoxy)-Propyl]-Diethyl-Amine
Rage Fusion Proteins and Methods of Use
Phenyl-Heteroaryl Derivatives and Methods of Use Thereof
RAGE Fusion Protein Compositions And Methods Of Use
Application:
13/062,395 →
Publication:
US 2013/0142792
Use of Metformin in Combination with a Glucokinase Activator and Compositions Comprising Metformin and a Glucokinase Activator
Nucleic Acid Molecules Encoding Rage Fusion Proteins
Control of RAGE Fusion Protein Glycosylation and RAGE Fusion Protein Compositions
Substituted Azoanthracene Derivatives, Pharmaceutical Compositions, and Methods of Use Thereof
Phenyl-Heteroaryl Derivatives and Methods of Use Thereof
Phenylglyoxylic Acid Derivatives and Their Preparation and Use
Oxadiazoanthracene Compounds for the Treatment of Diabetes
Substituted Imidazole Derivatives and Methods of Use Thereof
Treatment of Mild and Moderate Alzheimer's Disease
Glucokinase Activator Compositions for the Treatment of Diabetes
Oxadiazoanthracene Compounds for the Treatment of Diabetes
Phenyl-Heteroaryl Derivatives and Methods of Use Thereof
Tris(hydroxymethyl)Aminomethane Salts of a Small-Molecule GLP1R Agonist and Pharmaceutical Compositions and Uses Thereof
Oxadiazoanthracene Compounds for the Treatment of Diabetes
Substituted Azoanthracene Derivatives and Intermediates for Preparation Thereof
Related Assignments
(12)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 11, 2012
From: NOVO NORDISK A/S
To: TRANSTECH PHARMA, INC.
Reel/Frame 029112/0232 →
Confirmation of Termination of Exclusive Patent License
Jan 15, 2013
From: PFIZER, INC.
To: TRANSTECH PHARMA, INC.
Reel/Frame 029631/0111 →
Security Agreement
Aug 9, 2013
From: TRANSTECH PHARMA, INC.
To: M&F TTP HOLDINGS LLC C/O MACANDREWS & FORBES HOLDINGS INC.
Reel/Frame 030982/0803 →
Assignment of Assignor's Interest
Nov 22, 2013
From: TRANSTECH PHARMA, INC.
To: TRANSTECH PHARMA, LLC
Reel/Frame 031654/0878 →
Notice of Release of Security Interest in Patents for Reel/Frame 030982/0803
Apr 7, 2014
From: M&F TTP HOLDINGS LLC
To: TRANSTECH PHARMA, LLC
Reel/Frame 032621/0860 →
Security Interest
Feb 26, 2015
From: TRANSTECH PHARMA, LLC
To: M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT
Reel/Frame 035103/0356 →
Change of Name
Jun 25, 2015
From: TRANSTECH PHARMA, LLC
To: VTV THERAPEUTICS LLC
Reel/Frame 036026/0219 →
Change of Name
Jul 30, 2015
From: VTV THERAPEUTICS LLC
To: VTVX HOLDINGS I LLC
Reel/Frame 036236/0165 →
Assignment of Assignor's Interest
Jul 31, 2015
From: VTVX HOLDINGS I LLC
To: VTV THERAPEUTICS LLC
Reel/Frame 036242/0354 →
Release of Security Interest
Aug 3, 2015
From: M&F TTP HOLDINGS LLC, AS COLLATERAL AGENT
To: VTVX HOLDINGS II LLC
Reel/Frame 036254/0780 →
Security Interest
Apr 18, 2018
From: VTV THERAPEUTICS LLC
To: HORIZON TECHNOLOGY FINANCE CORPORATION, AS COLLATERAL AGENT
Reel/Frame 045969/0774 →
Release of Security Interest
Jan 27, 2021
From: HORIZON TECHNOLOGY FINANCE CORPORATION, AS COLLATERAL AGENT
To: VTV THERAPEUTICS LLC
Reel/Frame 055133/0214 →